Sen. Hawley: US Taxpayers Subsidize Big Pharma's Overpriced Drug Ads

US Drug Prices vs. Global Markets

• 🇺🇸 The United States pays significantly higher prices for prescription drugs than other developed nations, with one analysis showing costs are 250% higher than 32 comparison countries in 2021.
• 💡 Examples like insulin highlight this disparity, costing $98.70 per unit in the US compared to $6.94 in Australia and $12 in Canada.

Proposed Solutions for Lower Drug Costs

• 🎯 International reference pricing is suggested as a viable solution, where US prices would be capped at the average price in comparable global markets.
• ⚖️ Other proposed solutions include expanding price negotiation under the Inflation Reduction Act and patent reform to expedite the market entry of generics and biosimilars.
• 💸 The current system is described as unaffordable for many Americans, even those with insurance, due to astronomical drug costs.

Taxpayer Subsidies for Pharma Advertising

• 📺 Sen. Hawley argues that the US tax code effectively subsidizes pharmaceutical companies by allowing them to write off advertising costs for direct-to-consumer drug commercials.
• 💰 This practice is seen as subsidizing companies that already charge exorbitant prices, with Hawley calling for an end to this tax benefit.
• 🗣️ The witness agrees, noting that direct-to-consumer advertising of drugs is uncommon globally and a poor policy.

Consolidation in the Pharmacy Sector

• 📈 The rapid consolidation of pharmacies, including acquisitions by Pharmacy Benefit Managers (PBMs), is raising concerns about increased prices due to vertical integration.
• 🏥 PBMs are also acquiring doctor's practices and hospitals, leading to concentrated control over healthcare aspects.
• 🚫 Hawley expresses concern over the loss of independent pharmacies, with some counties in Missouri now having no pharmacies at all, while PBMs continue to profit.